ID

34566

Description

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics; ODM derived from: https://clinicaltrials.gov/show/NCT01685931

Link

https://clinicaltrials.gov/show/NCT01685931

Keywords

  1. 1/19/19 1/19/19 -
  2. 12/31/19 12/31/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Schizophrenia NCT01685931

Eligibility Schizophrenia NCT01685931

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
previous diagnosis of schizophrenia
Description

ID.1

Data type

boolean

experiencing an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120, inclusive
Description

ID.2

Data type

boolean

patients currently treated with antipsychotic are allowed to be recruited
Description

ID.3

Data type

boolean

be medically stable on the basis of clinical laboratory tests performed at screening
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
a primary diagnosis other than schizophrenia
Description

ID.5

Data type

boolean

history of risperidone or paliperidone resistance as defined by failure to respond to 2 adequate treatment periods
Description

ID.6

Data type

boolean

clozapine use for treatment refractory schizophrenia
Description

ID.7

Data type

boolean

relevant history or current presence of any significant or unstable condition, disease or illness that could limit the participation in the study according to the investigator
Description

ID.8

Data type

boolean

woman who is pregnant, breast-feeding, or is planning to become pregnant within 6 months
Description

ID.9

Data type

boolean

Similar models

Eligibility Schizophrenia NCT01685931

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
previous diagnosis of schizophrenia
boolean
ID.2
Item
experiencing an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120, inclusive
boolean
ID.3
Item
patients currently treated with antipsychotic are allowed to be recruited
boolean
ID.4
Item
be medically stable on the basis of clinical laboratory tests performed at screening
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
a primary diagnosis other than schizophrenia
boolean
ID.6
Item
history of risperidone or paliperidone resistance as defined by failure to respond to 2 adequate treatment periods
boolean
ID.7
Item
clozapine use for treatment refractory schizophrenia
boolean
ID.8
Item
relevant history or current presence of any significant or unstable condition, disease or illness that could limit the participation in the study according to the investigator
boolean
ID.9
Item
woman who is pregnant, breast-feeding, or is planning to become pregnant within 6 months
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial